A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers

PURPOSE: Dronedarone is a benzofuran derivative with a pharmacological profile similar to amiodarone but has a more rapid onset of action and a much shorter half-life (13–19 h). Our goal was to evaluate the efficacy of dronedarone in atrial fibrillation (AF) patients using dual-chamber pacemakers ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezekowitz, Michael D., Ellenbogen, Kenneth A., DiMarco, John P., Kaszala, Karoly, Boddy, Alexander, P., Gregory Geba, Koren, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346668/
https://www.ncbi.nlm.nih.gov/pubmed/25638303
http://dx.doi.org/10.1007/s10840-014-9966-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346668/
https://www.ncbi.nlm.nih.gov/pubmed/25638303
http://dx.doi.org/10.1007/s10840-014-9966-z

Ejemplares similares